フォルスコリン市場：現状分析および予測（2021年～2027年）

世界のフォルスコリンの市場規模は、予測期間（2021年～2027年）中に約8％のCAGRで拡大すると予測されています。肥満、緑内障、アレルギー、喘息などの疾病の増加や、新興経済諸国における医療インフラの充実も、同市場の成長を支える大きな要因となっています。

当レポートは、世界のフォルスコリン市場について調査し、市場の概要とともに、純度別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクション

第2章 調査方法または仮定

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 フォルスコリン市場に対するCOVID-19の影響

第6章 フォルスコリン市場収益、2019年～2027年

第7章 純度別の市場洞察

• 低濃度
• 中濃度
• 高濃度

第8章 用途別の市場洞察

• 栄養補助食品
• 体重管理
• 呼吸器疾患
• 心血管疾患
• 食品と飲料
• その他

第9章 地域別の市場洞察

• 北米
• 欧州
• アジア太平洋
• その他の地域

第10章 フォルスコリン市場の市場力学

• 市場促進要因
• 市場の課題
• 影響分析

第11章 フォルスコリン市場の機会

第12章 フォルスコリン市場の動向

第13章 法律および規制の枠組み

第14章 需要側と供給側の分析

第15章 バリューチェーン分析

第16章 競合シナリオ

• 競合情勢
  • ポーターのファイブフォース分析

第17章 会社概要

• Shaanxi Jiahe Phytochem Co., Ltd.
• Sabinsa Corporation
• Nutra Green Biotechnology Co. Ltd.
• Varion Lifesciences Pvt. Ltd.
• Bioprex Labs
• Alchem International Limited
• Flavour trove
• Cymbio Pharma Pvt. Ltd.
• Glentham Life Sciences
• Bayir Extracts Private Limited

第18章 免責事項

The forskolin market is expected to witness a CAGR of around 8% during the forecast period (2021-2027). Forskolin is an active compound extracted from the roots of a plant in the mint family. The market growth of this segment is mainly due to the increasing preference of consumers for naturally processed, ayurvedic products and herbal plants with medicinal benefits. Moreover, the rising prevalence of diseases such as obesity, glaucoma, allergies, asthma, etc., and strong healthcare infrastructure in developed economies are also the major factors for the growth of this segment. However, the outbreak of the COVID-19 pandemic impacted the market's growth as organizations experienced huge defers in obtaining the raw materials, they expected for producing medical care supplements from forskolin. Because of the imposed lockdown restrictions, a shortage of labor hampered the forskolin market's production. The rising awareness of natural products and plant-based products in beauty care products is supposed to support the market's development during the forecast period. For instance, according to the Centers for Medicare & Medicaid Services (CMS), U.S. health care spending grew 9.7 percent in 2020, reaching $4.1 trillion and Prescription drug spending increased 3.0% to $348.4 billion in 2020.

Some of the major companies operating in the forskolin market include Shaanxi Jiahe Phytochem Co., Ltd., Sabinsa Corporation, Nutra Green Biotechnology Co. Ltd., Varion Lifesciences Pvt. Ltd., Bioprex Labs, Alchem International Limited, Flavour trove, Cymbio Pharma Pvt. Ltd., Glentham Life Sciences, Bayir Extracts Private Limited

Insights Presented in the Report:

"Amongst Purity, the high concentration category accounted for the majority share in the market in 2020"

Based on purity, the forskolin market is segmented into low concentration, medium concentration, and high concentration. The high concentration category is anticipated to witness a significant growth rate during the forecast period. High concentration forskolin is extracted from the roots of the plants and this is the purest form of the forskolin. That is used in skincare and cosmetic products with anti-aging properties. The major factors for the growth of this category are rising cases of diseases such as CVDs, hypertension, insomnia, heart failure, etc. Furthermore, according to the American Heart Association, nearly half of adults in the U.S. have some type of CVD. By 2035, it is projected that more than 135 million adults, or 45.1% of the U.S. population are projected to have some form of CVD.

"Amongst Application, the dietary supplements category is expected to witness the highest CAGR during the forecast period"

Based on application, the forskolin market is segmented into dietary supplements, weight management, respiratory disorders, cardiovascular disorders, food & beverages, and others. The dietary supplements category is anticipated to witness a significant growth rate during the forecast period. owing to people consuming dietary supplements made from plants to complete their regular diet requirements and the dietary supplements widely being used in weight loss, digestive disorders, and pharmaceuticals, which propels the growth of the forskolin market during the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), the obesity prevalence was 39.8% among adults aged 20 to 39 years, 44.3% among adults aged 40 to 59 years, and 41.5% among adults aged 60 and older.

"North America to witness significant growth during the forecast period"

For a better understanding of the market, the report provides a detailed analysis of major regions and countries including North America (U.S., Canada, Rest of North America); Europe (Germany, U.K., France, Spain, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific) and Rest of World. In 2020, North America accounted for a significant market share. This is mainly due to the higher cases of cancer, obesity, heart failure, intestinal spasms, painful cramps (dysmenorrhea), high blood pressure (hypertension), chest pain, insomnia, etc. in this region. Moreover, the presence of major pharmaceutical companies, higher per capita income, and rising awareness of natural medications are the major key factor for the growth of this market during the forecast period. For instance, according to the U.S. Department of Health and Human Services (HHS), around 92.1 million adults with hypertension in the U.S. do not have their hypertension under control. This includes all 24.3 million adults who are recommended lifestyle modifications only and 67.8 million adults who are recommended lifestyle modifications and prescription medication.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The forskolin market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Limitation
• 1.3. Stakeholders
• 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Forskolin Market
• 2.2. Research Methodology of the Forskolin Market
• 2.3. Forecasting Method
• 2.4. Respondent Profile
• 2.5. Main Objective of the Forskolin Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 FORSKOLIN MARKET COVID-19 IMPACT

6 FORSKOLIN MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PURITY

• 7.1. Low Concentration
• 7.2. Medium Concentration
• 7.3. High Concentration

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Dietary Supplements
• 8.2. Weight Management
• 8.3. Respiratory Disorders
• 8.4. Cardiovascular Disorders
• 8.5. Food & Beverages
• 8.6. Others

9 MARKET INSIGHTS BY REGION

• 9.1. North America Forskolin Market
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe Forskolin Market
  • 9.2.1. Germany
  • 9.2.2. U.K.
  • 9.2.3. France
  • 9.2.4. Spain
  • 9.2.5. Italy
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific Forskolin Market
  • 9.3.1. China
  • 9.3.2. India
  • 9.3.3. Japan
  • 9.3.4. Australia
  • 9.3.5. South Korea
  • 9.3.6. Rest of Asia-Pacific
• 9.4. Rest of the world Forskolin Market

10 FORSKOLIN MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11 FORSKOLIN MARKET OPPORTUNITIES

12 FORSKOLIN MARKET TRENDS

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

• 14.1. Demand Side Analysis
• 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

• 16.1. Competitive Landscape
  • 16.1.1. Porter's Five Forces Analysis

17 COMPANY PROFILED

• 17.1. Shaanxi Jiahe Phytochem Co., Ltd.
• 17.2. Sabinsa Corporation
• 17.3. Nutra Green Biotechnology Co. Ltd.
• 17.4. Varion Lifesciences Pvt. Ltd.
• 17.5. Bioprex Labs
• 17.6. Alchem International Limited
• 17.7. Flavour trove
• 17.8. Cymbio Pharma Pvt. Ltd.
• 17.9. Glentham Life Sciences
• 17.10. Bayir Extracts Private Limited

18 DISCLAIMER